TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 213 filers reported holding TURNING POINT THERAPEUTICS I in Q2 2022. The put-call ratio across all filers is 3.08 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $252,000 | -41.8% | 9,403 | +3.5% | 0.08% | -31.0% |
| Q4 2021 | $433,000 | +8.2% | 9,083 | +50.8% | 0.11% | +3.7% |
| Q3 2021 | $400,000 | -32.9% | 6,023 | -21.2% | 0.11% | -35.5% |
| Q2 2021 | $596,000 | 0.0% | 7,643 | +21.3% | 0.17% | -7.7% |
| Q1 2021 | $596,000 | -13.5% | 6,303 | +11.5% | 0.18% | -15.3% |
| Q4 2020 | $689,000 | +25.5% | 5,653 | -10.0% | 0.22% | +7.5% |
| Q3 2020 | $549,000 | +31.7% | 6,283 | -2.6% | 0.20% | +21.8% |
| Q2 2020 | $417,000 | – | 6,450 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 2,750,000 | $260,122,000 | 5.80% |
| Burrage Capital Management LLC | 72,164 | $6,826,000 | 5.53% |
| Consonance Capital Management LP | 450,396 | $42,603,000 | 4.54% |
| MPM BioImpact LLC | 269,186 | $25,462,000 | 3.20% |
| Orbimed Advisors | 2,361,327 | $223,358,000 | 2.09% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 81,541 | $7,711,000 | 2.04% |
| SECTORAL ASSET MANAGEMENT INC | 257,879 | $24,393,000 | 1.85% |
| Nicholas Investment Partners, LP | 218,847 | $20,701,000 | 1.44% |
| Logos Global Management LP | 140,000 | $13,243,000 | 1.29% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 16,741 | $1,584,000 | 0.86% |